Print page   Email page   Download PDF   
« Previous Release | Next Release »

Myriad Genetics Announces Third Quarter Fiscal 2008 Financial Results Conference Call

Tuesday, May 6, 2008 at 10:00 a.m. ET

SALT LAKE CITY, UT, Apr 23, 2008 (MARKET WIRE via COMTEX News Network) -- Myriad Genetics, Inc. (NASDAQ: MYGN) has arranged a conference call with the management team to provide a company update. Peter D. Meldrum, President and Chief Executive Officer, will host the call along with Jim Evans, Chief Financial Officer; Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc.; and Adrian N. Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.

DATE: May 6, 2008
TIME: 10:00 am ET
DOMESTIC DIAL-IN: (800) 926-4420
INTERNATIONAL DIAL-IN: (212) 231-2905
RESERVATION NO.: 21381718
(Please dial in approximately 10 minutes before the call is scheduled to
begin)

A press release will be issued at 6:30 am ET.

Replay of the call will be available from two hours after the call for seven days. It can be accessed by dialing (800) 633-8284 from the United States, or +1 402 977 9140 internationally, and entering the reservation number.

Live audio webcast of the call will be available at: www.myriad.com

Contact:
Suzanne Barton
Myriad Genetics
(801) 584-1138

SOURCE: Myriad Genetics, Inc.